October 22, 2012

Pfizer is buying the maker of an attention deficit hyperactivity disorder drug for almost $700 million, Pfizer said Monday.

October 19, 2012

Through a $100,000 gift to the Fashion Institute of Technology, an endowed scholarship has been established by cosmetics executive Leslie Blodgett, creator of BareMinerals and executive chairman of Bare Escentuals.

October 18, 2012

While Supervalu has completed its overhaul of its value proposition across its Jewel-Osco banner, the grocer will be analyzing the impact before replicating the price repositioning across its entire chain.

September 27, 2012

Physicians Formula and Markwins International announced on Thursday that they have entered into a merger agreement under which Markwins will acquire all of the outstanding shares of common stock of Physicians Formula for $4.90 per share in cash, or approximately $74.9 million.

September 25, 2012

Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

September 25, 2012

As the largest single purchaser of prescription drugs in the world, with a global pharmaceutical wholesale operation to match, in-house manufacturing capabilities in over-the-counter health and wellness and generic drugs, Walgreens-Alliance Boots will have a whole lot more influence on the pharmacy side of its business.


September 19, 2012

Beauty company Coty has appointed Jean Mortier as president of its Prestige business, effective immediately.

September 18, 2012

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.


September 5, 2012

Kimberly-Clark has issued a consumer advisory — as a result of suspected criminal activity — regarding a number of defective lots of Kotex Natural Balance Security tampons that may pose public health risks to consumers.

September 5, 2012

Yellow Wood Partners has acquired mass market fragrance provider Parfums de Coeur, whose brands include Body Fantasies, Designer Imposters and BOD Man.

September 4, 2012

Canadian drug maker Valeant Pharmaceuticals International is buying Medicis Pharmaceutical for $2.6 billion, Valeant said Monday.

August 28, 2012

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

August 24, 2012

As several suitors eye individual parts of the Supervalu business, Bloomberg reported that Supervalu is seeking buyers to bid for the entire business.

August 10, 2012

BioScrip on Wednesday posted $155.9 million in second-quarter revenue, up 18.5% compared with the prior year.

August 8, 2012

Bristol-Myers Squibb has bought a majority stake in drug maker Amylin Pharmaceuticals, Bristol said Wednesday.

August 1, 2012

Beiersdorf’s Nivea brand has announced the launch of its first-ever Nivea "Kiss of Style" design contest, which will give one winner the opportunity to design a limited-edition cap for Nivea Lip Care that will be sold in stores.

August 1, 2012

Campbell's confirmed that a new leader will take over the company's Pepperidge Farm business.

July 31, 2012

An Ahold USA executive has received honors from a New England business publication.

July 27, 2012

McLane has entered into an agreement to acquire Meadowbrook Meat Co.

July 20, 2012

A division of Nestle has bought a stake in a Colorado-based drug maker focused on treatments for neurodegenerative diseases.

July 11, 2012

Land O'Lakes announced it has agreed to acquire Kozy Shack.

July 9, 2012

Jel Sert has acquired three functional beverage brand names from Solis Brands.

July 9, 2012

Narrow networks. They're all the rage.

July 2, 2012

Bristol-Myers Squibb is acquiring Amylin Pharmaceuticals, the drug maker said Friday.